Our vocation is to develop first-in-class innovative drugs to treat patients with degenerative or traumatic neurological disorders
Our ambition is to improve the recovery of the functionality and the quality of life of patients.
During embryogenesis, a small organ named Subcommisural Organ (SCO) located in the dorsal roof of the brain differentiates and secrets the SCO-spondin, a large multi-domain protein widely distributed in the CNS and with potent activity during neurogenesis.
Our products are first-in-class multi-target patented peptides with high potential in many CNS disorders, as demonstrated via distinctive and multifunctional mechanism of action on neural cells.
Neurological disorders are diseases of the central and peripheral nervous system. These disorders are of major clinical problems with high unmet medical needs and currently no satisfactory treatment.